Affymetrix GeneChip Arrays Elevated In Roche Pact, Considered By FDA
This article was originally published in The Gray Sheet
Executive Summary
Affymetrix' plans to establish its GeneChip as the standard platform technology for genomics-based diagnostics are bolstered by FDA enthusiasm for the probe microarrays, the company claims